A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2014

Study Completion Date

November 30, 2014

Conditions
CancerCachexia
Interventions
OTHER

Multimodal intervention

Nutritional supplements aimed at optimal energy balance and protein intake (2 cartons of ProSure per day), nutritional advice, home-based self-assisted exercise program and anti-inflammatory treatment (300 mg celecoxib) for 6 weeks. The aerobic exercise program is performed as self-administered daily walking sessions, aiming for a minimum of two sessions 30 minutes on a weekly basis. Other aerobic activities could be used instead of walking. The resistance exercise program should be performed 3 times weekly and lasts about 20 minutes. The program is targeting major muscle groups in the upper body and legs with use of weights. The intensity of the exercise and performance of the exercises are adapted to the individual patient's disease burden and physical performance.

OTHER

Standard care

Standard cancer care

Trial Locations (3)

Unknown

Oslo University Hospital Ullevål, Oslo

St Olavs Hospital, Trondheim

University of Edinburgh, Edinburgh

All Listed Sponsors
collaborator

University of Edinburgh

OTHER

collaborator

Oslo University Hospital

OTHER

collaborator

NHS Greater Glasgow and Clyde

OTHER

collaborator

Copenhagen University Hospital at Herlev

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT01419145 - A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study | Biotech Hunter | Biotech Hunter